MedPath

The effect of celox powder on hemostasis of vasscular access in hemodialysis pateint.

Not Applicable
Conditions
hemodialysis.
Care involving dialysis
Registration Number
IRCT2013072813968N2
Lead Sponsor
Mashhad University of Medical Sciences Vice chancellor for research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
11
Inclusion Criteria

inclusion criteria: Have consent for participant in study; three time in week treatment with hemodialysis ; vascular access is fistful; age of 18-75 ; Time to hemostasis 0f vascular puncture site is eight minutes or more of eight minutes.
Exclusion criteria:Not Orient to place, person and time ; have coagulopathy problem and abnormal bleeding.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemostasis. Timepoint: till to hemostasis. Method of measurement: cronometr.
Secondary Outcome Measures
NameTimeMethod
Rebleeding. Timepoint: After 48 hours. Method of measurement: Quational form.;Alergy. Timepoint: After 48 hours. Method of measurement: Quational form.
© Copyright 2025. All Rights Reserved by MedPath